MedTrace Logo

Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)

NCT00357422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-09-10

No results posted yet for this study

Summary

The purpose of this study is to choose the preferred treatment modality for solitary, small hepatocellular carcinoma.

Conditions

Interventions

PROCEDURE

Operation

No drug needed

PROCEDURE

Percutaneous ethanol injection therapy

99% ethanol, 2-4cc per one session, two to three sessions per single procedure for one week

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • J H Yoon, Professor · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00357422 on ClinicalTrials.gov